Drawing for DIFGEN

USPTO serial 97513094

DIFGEN

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
Examiner
ROSSMAN, WILLIAM M
Law office
TMEG LAW OFFICE 109

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DIFGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristin Grant

Kristin Grant GRANT ATTORNEYS AT LAW PLLC1185 6th Avenue, 3rd FloorNEW YORK, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Dental waxes; Dietetic preparations adapted for medical purposes; Disinfectants; Food for babies; Fungicides; Herbicides; Material for stopping teeth; Plasters for medical purposes; Medical and surgical dressings; Preparations for destroying vermin; Sanitary preparations for medical purposes; Veterinary preparations for cows, buffalos, cats, dogs, horses, pets, camels, birds, goats, sheep, chickens, rabbits, fish for treatment of infectious diseases due to bacteria, viruses, worms and other microorganisms; Veterinary preparations for the prevention and treatment of cardiovascular, brain, nervous system, endocrine, immune system, ophthalmic, digestive system, excretory, respiratory system, renal, reproductive system, sensory, muscular system, skeletal system, pain, eye, ear, nose, hair, dermal, kidney, liver, pancreas, dental, buccal, pediatric, gynecological, congenital, blood, and prostate related diseases and disorders; Pharmaceutical preparations for prevention and treatment of cardiovascular, brain, nervous system, endocrine, immune system, ophthalmic, digestive system, excretory, respiratory system, renal, reproductive system, sensory, muscular system, skeletal system, pain, eye, ear, nose, hair, dermal, kidney, liver, pancreas, dental, buccal, pediatric, gynecological, congenital, blood, prostate, and psychiatric related diseases and disorders; Pharmaceutical preparations for prevention and treatment of cancer, diabetes, asthma, depression, hypertension, schizophrenia, Parkinson's, and bipolar disorder, infectious diseases, due to bacteria, virus, fungus, and protozoa, tuberculosis, stroke, diarrhea, osteoporosis, arthritis, obesity, and allergies; Pharmaceutical preparations for use in anesthesia and radiotherapy; Pharmaceutical preparations for medical imaging purposes; Pharmaceutical preparations for nutritional purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 24, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 23, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 14, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 14, 2025GNSLLETTER OF SUSPENSION E-MAILED
Nov 14, 2025CNSLSUSPENSION LETTER WRITTEN
Jun 26, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 26, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 26, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 26, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 26, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 2, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 2, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 2, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 24, 2023JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Jul 24, 2023ISPOWITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Jun 27, 2023APETASSIGNED TO PETITION STAFF
Jun 27, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 27, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 12, 2023EPPATEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 7, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 24, 2023FIXDELECTRONIC RECORD REVIEW COMPLETE
May 19, 2023ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 16, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2023DOCKASSIGNED TO EXAMINER
Aug 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance